Bioscan Research: Financial Breakdown
Decoding financial health metrics of Bioscan Research
Total Revenue₹13.4 Cr-4%Prev. FY
Total Expenses₹12.1 Cr-13%Prev. FY
Profit After Tax₹1.1 Cr724%Prev. FY
Total Assets₹7.2 Cr105%Prev. FY
Net Profit Margin7.9%756%Prev. FY
FAQs on Financials of Bioscan Research
Yes. In FY25, Bioscan Research reported a profit after tax of ₹1.1 Cr, making it profitable.
Bioscan Research's revenue declined 3.9% year-on-year, from ₹13.9 Cr in FY24 to ₹13.4 Cr in FY25.
Bioscan Research's estimated EBITDA for FY25 was ₹1.3 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Bioscan Research posted revenue of ₹13.4 Cr (down 3.9% YoY) and a profit after tax of ₹1.1 Cr. Explore the full financials of Bioscan Research here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links